| Literature DB >> 26567916 |
Carlo Biz1, Davide Pavan2, Antonio Frizziero3, Ala Baban4, Claudio Iacobellis5.
Abstract
BACKGROUND: Our purpose was to record the incidence of heterotopic ossification (HO) following hip replacement by different variables to identify patient groups that are likely to develop HO in the absence of a prophylactic protocol.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26567916 PMCID: PMC4644335 DOI: 10.1186/s13018-015-0317-2
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Distribution of the diagnoses of a diseased hip. a Main diagnoses. b Diagnoses included under “others”
Fig. 2Frequencies of HO according to Brooker classification
Fig. 3Case of severe heterotopic ossifications. HOs developed in a patient who had been moved to the emergency room after ceramic-ceramic THR because of her critical condition. The patient remained motionless for 1 month after hip replacement, and 1 year later, heterotopic ossifications were removed (a, b)
Distribution of development of heterotopic ossifications (HO) among patients by rank
| Character | Rank | Presence of HO (%) | Absence of HO (%) |
|
|---|---|---|---|---|
| Age | Mean age = 77.6 years | Mean age = 80.2 years | 0.0018 | |
| Sex | Male | 64.4 | 35.6 | 0.1011 |
| Female | 57.7 | 42.3 | ||
| Diagnosis of diseased hip | Coxarthrosis | 72.7 | 27.3 | 0.0001 |
| Femoral neck fracture | 55.9 | 44.1 | ||
| Others | 82.9 | 17.1 | ||
| Previous HO | Presence | 76.2 | 23.8 | 0.0260 |
| Absence | 58.8 | 41.2 | ||
| Surgical approach to the hip | Watson-Jones | 55.6 | 44.4 | 0.0163 |
| Hardinge-Bauer | 65.5 | 34.5 | ||
| Kind of implant | Ceramic-ceramic THR | 68.1 | 31.9 | 0.0001 |
| Partial prosthesis | 51.3 | 48.7 | ||
| TriboFit® system | 67.0 | 33.0 | ||
| Previous surgery of the ipsilateral hip (only among ceramic-ceramic THR) | Presence | 75.0 | 25.0 | 0.4896 |
| Absence | 67.5 | 32.5 |
Odds ratio estimates for those variables that showed to increase the development of periarticular HO individually during multivariate analysis
| Effect | Point estimate | 95 % Wald confidence limits |
|---|---|---|
| TriboFit® vs endoprosthesis | 1.976 | 1.251–3.121 |
| Ceramic-ceramic-coupled THR vs endoprosthesis | 1.911 | 1.326–2.752 |
| Presence of previous HO vs absence of previous HO | 2.322 | 1.073–5.025 |
HO heterotopic ossification
Distribution of development of heterotopic ossifications (HO) among patients by the grade of HO
| Character | Rank | HO grade by Brooker classification (%) |
| |||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| Sex | Male | 26.5 | 28.7 | 34.5 | 10.3 | 0.0478 |
| Female | 39.0 | 26.8 | 28.7 | 5.5 | ||
| Diagnosis of diseased hip | Coxarthrosis | 40.3 | 20.8 | 29.2 | 9.7 | 0.3278 |
| Femoral neck fracture | 33.6 | 28.4 | 32.1 | 5.9 | ||
| Others | 31.0 | 34.5 | 20.7 | 13.8 | ||
| Previous HO | Presence | 40.6 | 38.4 | 15.6 | 9.4 | 0.2830 |
| Absence | 34.1 | 26.8 | 32.1 | 7.0 | ||
| Surgical approach to the hip | Watson-Jones | 38.1 | 28.7 | 26.9 | 6.3 | 0.1738 |
| Hardinge-Bauer | 30.8 | 24.7 | 37.0 | 7.5 | ||
| Kind of implant | Ceramic-ceramic THR | 37.2 | 25.6 | 26.9 | 10.3 | 0.0093 |
| Partial prosthesis | 35.2 | 33.3 | 27.1 | 4.4 | ||
| TriboFit® system | 28.0 | 18.7 | 46.7 | 6.6 | ||
Fig. 4Examples of radiographic high-graded heterotopic ossification for each kind of implant within our cohort. a Ceramic-ceramic-coupled total hip replacement. b TriboFit®. c Endoprosthesis